Assignment of Assignor's Interest

Recorded: 2004-01-15 Received: 2004-01-27 Pages: 5

Assignor

MILLENNIUM PHARMACEUTICALS, INC.

Executed: 2003-11-07

Assignee

PORTOLA PHARMACEUTICALS, INC.

270 E. GRAND AVENUE, SUITE 22, SOUTH SAN FRANCISCO, CA, 94080, UNITED STATES

Covered Properties (8)

2,4-Dioxo-3-quinazolinylaryl sulfonylureas

Application: 60/508,564 →

Substituted isoquinolinones

Application: 60/508,402 →

Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors

Application: 10/275,154 →

Platlet Adp Receptor Inhibitors

Application: 10/350,883 →

4-Thieno[2,3-D]Pyrimidin-4-Yl Piperazine Compounds

Application: 10/237,153 →

Bicyclic fused heterocyclic platelet ADP receptor inhibitors

Application: 60/317,192 →

Platelet Adp Receptor Inhibitors

Application: 09/920,325 →

Platelet Adp Receptor Inhibitors

Application: 09/775,812 →